Articles with the topic: growth-factors

A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?

A multiple sclerosis drug that works for Huntington's disease: the real deal or too good to be true?

Fingolimod, a drug used in multiple sclerosis, prevents memory problems in HD mice. Would it work in patients?

Melissa ChristiansonNovember 24, 2015

Unlocking the Potential of Antibodies as a Therapy for Huntington’s Disease

Unlocking the Potential of Antibodies as a Therapy for Huntington’s Disease

Antibodies are known for their role in immunity, but researchers repurpose them in many ways. Can they be used in HD?

Lakshini MendisFebruary 18, 2015

New results bring BDNF therapies into focus

New results bring BDNF therapies into focus

Some unexpected findings suggest new ways to aim at an old target in HD

Dr Jeff CarrollAugust 18, 2014

Raptor announces results of cysteamine trial for Huntington's disease

Raptor announces results of cysteamine trial for Huntington's disease

Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease

Dr Jeff CarrollApril 10, 2014

Is a new Huntington’s Disease drug study on the right Trk?

Is a new Huntington’s Disease drug study on the right Trk?

A recent HD animal study reveals that a small molecule drug could be an effective “Trk” to target for HD therapeutics

Joseph OchabaJanuary 02, 2014

CHDI Report: Day 3

CHDI Report: Day 3

Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies

Dr Jeff CarrollFebruary 10, 2011